Champions Oncology, Inc. (NASDAQ:CSBR)

BRIEF

published on 03/30/2026 at 17:00, 4 hours 16 minutes ago

Champions Oncology Appoints Brian Alexander to Board, Highlights Data-Focused Strategy

Data Strategy Champions Oncology Brian Alexander Oncology R&D Tumor Models
PRESS RELEASE

published on 03/30/2026 at 16:55, 4 hours 21 minutes ago

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Champions Oncology appoints Dr. Brian Alexander to its Board of Directors, enhancing its focus on leveraging clinically relevant data for oncology R&D. The appointment strengthens the company's strategy of using data to drive drug discovery and development

Champions Oncology Brian Alexander Oncology R&D Clinically Relevant Data Translational Research
BRIEF

published on 07/08/2025 at 14:35, 8 months 22 days ago

Champions Oncology Launches Comprehensive Radiopharmaceutical Platform

PDX Models Radioligand Therapy Oncology Drug Development Radiopharmaceutical Services Isotope License
PRESS RELEASE

published on 07/08/2025 at 14:30, 8 months 22 days ago

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Champions Oncology announces the full commercial launch of its radiopharmaceutical services platform, offering integrated radiopharmaceutical studies with clinically relevant isotopes and PDX tumor models

Oncology Research Radiopharmaceuticals Champions Oncology PDX Tumor Models Radioactive Isotopes
BRIEF

published on 04/28/2025 at 15:50, 11 months 2 days ago

Champions Oncology Secures Radioactive Materials License for Radiotherapeutic Research

PDX Models Radiotherapeutics Champions Oncology Radioactive Materials Translational Oncology
PRESS RELEASE

published on 04/28/2025 at 15:45, 11 months 2 days ago

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Champions Oncology granted license for radioactive materials in preclinical studies, enhancing capabilities in radiotherapeutics development. CEO Ronnie Morris highlights the importance of this milestone

Preclinical Studies Radiotherapeutics Champions Oncology Radioactive Materials Biopharmaceutical Partners
BRIEF

published on 01/08/2025 at 14:05, 1 year 2 months ago

Champions Oncology Expands Bioanalytical Services with New Technology

Oncology Research Champions Oncology Bioanalytical Services Cytek Aurora Troy Tremaine
PRESS RELEASE

published on 01/08/2025 at 14:00, 1 year 2 months ago

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Champions Oncology announces advancements in bioanalytical services portfolio with Cytek Aurora flow cytometers integration and appointment of Troy Tremaine, MBA, for Commercial Strategy

Commercial Strategy Champions Oncology Bioanalytical Services Cytek Aurora Troy Tremaine
PRESS RELEASE

published on 11/02/2023 at 13:30, 2 years 4 months ago

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Published on 03/30/2026 at 20:45, 31 minutes ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/30/2026 at 16:55, 4 hours 21 minutes ago

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Published on 03/30/2026 at 16:25, 4 hours 51 minutes ago

CORRECTION: Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World
Published on 03/30/2026 at 15:15, 6 hours 1 minute ago

Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World
Published on 03/30/2026 at 14:30, 6 hours 46 minutes ago

Namibia Critical Metals and JOGMEC Amend Agreement to Increase Earn-In Funding for the Lofdal Heavy Rare Earths Project

View all ACCESSWIRE

Published on 03/30/2026 at 20:40, 36 minutes ago

Orderfox Schweiz AG Introduces Gieni ABX in collaboration with Microsoft: A Frontier AI Solution That Executes Work to Completion
Published on 03/30/2026 at 19:20, 1 hour 56 minutes ago

Basler publishes audited 2025 financial statements, including a forecast for 2026, and approves a dividend resolution
Published on 03/30/2026 at 18:28, 2 hours 47 minutes ago

AEVIS VICTORIA SA (AEVS) - Infracore SA - See-Spital strengthens its financial foundation through a long-term infrastructure partnership with Infracore
Published on 03/30/2026 at 18:22, 2 hours 54 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/30/2026 at 17:36, 3 hours 39 minutes ago

EQS-Adhoc: Daldrup & Söhne AG exceeds its 2025 earnings forecast based on preliminary figures, achieving a consolidated EBIT margin of 17.4% - on total consolidated output of EUR 50.8 million

View all EQS

Published on 03/30/2026 at 18:45, 2 hours 31 minutes ago

ENGIE is expanding its power transmission activities in Brazil with the award of new concessions
Published on 03/30/2026 at 17:48, 3 hours 28 minutes ago

Reporting on share buyback transactions carried out between March 23 and March 27, 2026
Published on 03/30/2026 at 17:45, 3 hours 31 minutes ago

Weekly share buyback
Published on 03/30/2026 at 17:35, 3 hours 41 minutes ago

2025 UNIVERSAL REGISTRATION DOCUMENT
Published on 03/27/2026 at 19:06, 3 days 2 hours ago

Mersen: Disclosure of trading own shares

View all LES ECHOS COMFI WIRE

News